Olema Pharmaceuticals Inc...

NASDAQ: OLMA · Real-Time Price · USD
5.52
0.26 (4.94%)
At close: Aug 15, 2025, 3:59 PM
5.54
0.36%
After-hours: Aug 15, 2025, 06:03 PM EDT

Olema Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
393K 377K 1.66M 1.66M
Gross Profit
-393K -377K -1.66M -1.66M
Operating Income
-142.26M -104.96M -106.99M -71.49M
Interest Income
12.68M 8.32M 2.23M 442K
Pretax Income
-129.47M -96.66M -104.79M -71.1M
Net Income
-129.47M -96.66M -104.79M -70.89M
Selling & General & Admin
17.74M 18.82M 24.71M 20.39M
Research & Development
124.52M 86.14M 82.27M 51.1M
Other Expenses
n/a n/a -27K -47K
Operating Expenses
142.26M 104.58M 106.99M 71.49M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-142.26M 104.96M 106.99M 71.49M
Income Tax Expense
n/a n/a n/a -210K
Shares Outstanding (Basic)
58.74M 45.25M 40M 39.52M
Shares Outstanding (Diluted)
58.74M 45.25M 40M 39.52M
EPS (Basic)
-2.2 -2.14 -2.62 -1.79
EPS (Diluted)
-2.2 -2.14 -2.62 -1.79
EBITDA
-129.08M -104.58M -106.63M -69.43M
EBIT
-129.47M -96.66M -104.79M -71.1M
Depreciation & Amortization
393K 377K 357K 1.66M